Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1432686
PUBLISHER: KBV Research | PRODUCT CODE: 1432686
LAMEA Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Pharmaceutical Suspension Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).
Pharmaceutical suspension is a liquid dosage form in which solid particulates are dispersed finely throughout a liquid medium. It is a versatile drug delivery system that can be administered orally or parenterally. The uniform dispersion of the solid particles, usually insoluble medications, in the liquid, prevents them from settling. Stability and bioavailability are improved by this formulation, especially for poorly soluble medications. Pharmaceutical suspensions provide advantages like ease of administration, increased patient compliance, and dosage flexibility. Their versatility makes them appropriate for a broad range of medications, contributing to their widespread use in the pharmaceutical sector.
Pharmaceutical suspensions cater to a broad spectrum of patients, making them highly adaptable across various demographic segments. From pediatric patients who prefer liquid formulations to elderly individuals having trouble swallowing, suspensions address the unique needs of different age groups, contributing to their widespread adoption. The solubility challenges associated with certain drugs can limit their therapeutic effectiveness. Pharmaceutical suspensions offer a solution by enhancing the bioavailability of poorly soluble compounds, ensuring that a greater proportion of the drug reaches the systemic circulation. This improved efficacy encourages the adoption of suspensions for drugs with bioavailability concerns.
As per the National Library of Medicine, the Middle East has a high rate of cardiovascular disease (10.1%). In this region, the prevalence of dyslipidemia (43.3%) is double that of hypertension (26.2%) and diabetes mellitus (16%). Multifaceted interventions are desperately needed in this region for CVD primary prevention. Thus, due to these aspects, the pharmaceutical suspension market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Pharmaceutical Suspension Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,679.6 million by 2030. The Argentina market is showcasing a CAGR of 7.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 5.8% during (2023 - 2030).
Based on Type, the market is segmented into Parenteral, Oral, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on End User, the market is segmented into Hospitals and Clinics, Home Care Settings, and Others. Based on Indication, the market is segmented into Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Merck & Co., Inc.
- Bayer AG
- Sanofi S.A.
- Pfizer, Inc.
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly And Company
- Lupin Limited
LAMEA Pharmaceutical Suspension Market Report Segmentation
By Type
- Parenteral
- Oral
- Others
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
By Indication
- Cancer
- Neurological
- Infectious Diseases
- Gastrointestinal
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Pharmaceutical Suspension Market, by Type
- 1.4.2 LAMEA Pharmaceutical Suspension Market, by Distribution Channel
- 1.4.3 LAMEA Pharmaceutical Suspension Market, by End User
- 1.4.4 LAMEA Pharmaceutical Suspension Market, by Indication
- 1.4.5 LAMEA Pharmaceutical Suspension Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter's Five Forces Analysis
Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market
Chapter 5. LAMEA Pharmaceutical Suspension Market by Type
- 5.1 LAMEA Parenteral Market by Country
- 5.2 LAMEA Oral Market by Country
- 5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Pharmaceutical Suspension Market by Distribution Channel
- 6.1 LAMEA Drug Store & Retail Pharmacies Market by Country
- 6.2 LAMEA Hospital Pharmacies Market by Country
- 6.3 LAMEA Online Providers Market by Country
Chapter 7. LAMEA Pharmaceutical Suspension Market by End User
- 7.1 LAMEA Hospitals and Clinics Market by Country
- 7.2 LAMEA Home Care Settings Market by Country
- 7.3 LAMEA Others Market by Country
Chapter 8. LAMEA Pharmaceutical Suspension Market by Indication
- 8.1 LAMEA Cancer Market by Country
- 8.2 LAMEA Neurological Market by Country
- 8.3 LAMEA Infectious Diseases Market by Country
- 8.4 LAMEA Gastrointestinal Market by Country
- 8.5 LAMEA Others Market by Country
Chapter 9. LAMEA Pharmaceutical Suspension Market by Country
- 9.1 Brazil Pharmaceutical Suspension Market
- 9.1.1 Brazil Pharmaceutical Suspension Market by Type
- 9.1.2 Brazil Pharmaceutical Suspension Market by Distribution Channel
- 9.1.3 Brazil Pharmaceutical Suspension Market by End User
- 9.1.4 Brazil Pharmaceutical Suspension Market by Indication
- 9.2 Argentina Pharmaceutical Suspension Market
- 9.2.1 Argentina Pharmaceutical Suspension Market by Type
- 9.2.2 Argentina Pharmaceutical Suspension Market by Distribution Channel
- 9.2.3 Argentina Pharmaceutical Suspension Market by End User
- 9.2.4 Argentina Pharmaceutical Suspension Market by Indication
- 9.3 UAE Pharmaceutical Suspension Market
- 9.3.1 UAE Pharmaceutical Suspension Market by Type
- 9.3.2 UAE Pharmaceutical Suspension Market by Distribution Channel
- 9.3.3 UAE Pharmaceutical Suspension Market by End User
- 9.3.4 UAE Pharmaceutical Suspension Market by Indication
- 9.4 Saudi Arabia Pharmaceutical Suspension Market
- 9.4.1 Saudi Arabia Pharmaceutical Suspension Market by Type
- 9.4.2 Saudi Arabia Pharmaceutical Suspension Market by Distribution Channel
- 9.4.3 Saudi Arabia Pharmaceutical Suspension Market by End User
- 9.4.4 Saudi Arabia Pharmaceutical Suspension Market by Indication
- 9.5 South Africa Pharmaceutical Suspension Market
- 9.5.1 South Africa Pharmaceutical Suspension Market by Type
- 9.5.2 South Africa Pharmaceutical Suspension Market by Distribution Channel
- 9.5.3 South Africa Pharmaceutical Suspension Market by End User
- 9.5.4 South Africa Pharmaceutical Suspension Market by Indication
- 9.6 Nigeria Pharmaceutical Suspension Market
- 9.6.1 Nigeria Pharmaceutical Suspension Market by Type
- 9.6.2 Nigeria Pharmaceutical Suspension Market by Distribution Channel
- 9.6.3 Nigeria Pharmaceutical Suspension Market by End User
- 9.6.4 Nigeria Pharmaceutical Suspension Market by Indication
- 9.7 Rest of LAMEA Pharmaceutical Suspension Market
- 9.7.1 Rest of LAMEA Pharmaceutical Suspension Market by Type
- 9.7.2 Rest of LAMEA Pharmaceutical Suspension Market by Distribution Channel
- 9.7.3 Rest of LAMEA Pharmaceutical Suspension Market by End User
- 9.7.4 Rest of LAMEA Pharmaceutical Suspension Market by Indication
Chapter 10. Company Profiles
- 10.1 Merck & Co., Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 SWOT Analysis
- 10.2 Bayer AG
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
- 10.3 Sanofi S.A.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 SWOT Analysis
- 10.4 Pfizer, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
- 10.5 Novartis AG
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 SWOT Analysis
- 10.6 AstraZeneca PLC
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
- 10.6.5.1 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
- 10.7 Glenmark Pharmaceuticals Limited
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 SWOT Analysis
- 10.8 Teva Pharmaceutical Industries Ltd.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expenses
- 10.8.5 Recent strategies and developments:
- 10.8.5.1 Product Launches and Product Expansions:
- 10.8.6 SWOT Analysis
- 10.9 Eli Lilly And Company
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
- 10.10. Lupin Limited
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
- 10.10.5.1 Partnerships, Collaborations, and Agreements:
- 10.10.5.2 Trials and Approvals:
- 10.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 2 LAMEA Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 3 LAMEA Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 4 LAMEA Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 5 LAMEA Parenteral Market by Country, 2019 - 2022, USD Million
- TABLE 6 LAMEA Parenteral Market by Country, 2023 - 2030, USD Million
- TABLE 7 LAMEA Oral Market by Country, 2019 - 2022, USD Million
- TABLE 8 LAMEA Oral Market by Country, 2023 - 2030, USD Million
- TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 11 LAMEA Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 12 LAMEA Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 13 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 14 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 15 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 16 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 17 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
- TABLE 18 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
- TABLE 19 LAMEA Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 20 LAMEA Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 21 LAMEA Hospitals and Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 22 LAMEA Hospitals and Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 23 LAMEA Home Care Settings Market by Country, 2019 - 2022, USD Million
- TABLE 24 LAMEA Home Care Settings Market by Country, 2023 - 2030, USD Million
- TABLE 25 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 26 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 27 LAMEA Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 28 LAMEA Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 29 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
- TABLE 30 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
- TABLE 31 LAMEA Neurological Market by Country, 2019 - 2022, USD Million
- TABLE 32 LAMEA Neurological Market by Country, 2023 - 2030, USD Million
- TABLE 33 LAMEA Infectious Diseases Market by Country, 2019 - 2022, USD Million
- TABLE 34 LAMEA Infectious Diseases Market by Country, 2023 - 2030, USD Million
- TABLE 35 LAMEA Gastrointestinal Market by Country, 2019 - 2022, USD Million
- TABLE 36 LAMEA Gastrointestinal Market by Country, 2023 - 2030, USD Million
- TABLE 37 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 38 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 39 LAMEA Pharmaceutical Suspension Market by Country, 2019 - 2022, USD Million
- TABLE 40 LAMEA Pharmaceutical Suspension Market by Country, 2023 - 2030, USD Million
- TABLE 41 Brazil Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 42 Brazil Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 43 Brazil Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 44 Brazil Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 45 Brazil Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 46 Brazil Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 47 Brazil Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 48 Brazil Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 49 Brazil Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 50 Brazil Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 51 Argentina Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 52 Argentina Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 53 Argentina Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 54 Argentina Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 55 Argentina Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 Argentina Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 Argentina Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 58 Argentina Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 59 Argentina Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 60 Argentina Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 61 UAE Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 62 UAE Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 63 UAE Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 64 UAE Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 65 UAE Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 UAE Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 67 UAE Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 68 UAE Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 69 UAE Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 70 UAE Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 71 Saudi Arabia Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 72 Saudi Arabia Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 73 Saudi Arabia Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 74 Saudi Arabia Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 75 Saudi Arabia Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 76 Saudi Arabia Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 77 Saudi Arabia Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 78 Saudi Arabia Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 79 Saudi Arabia Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 80 Saudi Arabia Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 81 South Africa Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 82 South Africa Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 83 South Africa Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 84 South Africa Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 85 South Africa Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 86 South Africa Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 87 South Africa Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 88 South Africa Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 89 South Africa Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 90 South Africa Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 91 Nigeria Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 92 Nigeria Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 93 Nigeria Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 94 Nigeria Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 95 Nigeria Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 96 Nigeria Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 97 Nigeria Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 98 Nigeria Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 99 Nigeria Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 100 Nigeria Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 101 Rest of LAMEA Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 102 Rest of LAMEA Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 103 Rest of LAMEA Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 104 Rest of LAMEA Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 105 Rest of LAMEA Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 106 Rest of LAMEA Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 107 Rest of LAMEA Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 108 Rest of LAMEA Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 109 Rest of LAMEA Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 110 Rest of LAMEA Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 111 Key Information - Merck & Co., Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Sanofi S.A.
- TABLE 114 Key Information - Pfizer, Inc.
- TABLE 115 Key Information - Novartis AG
- TABLE 116 KEY INFORMATION - AstraZeneca PLC
- TABLE 117 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 118 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 119 Key Information - Eli Lilly And Company
- TABLE 120 Key Information - Lupin Limited
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.